🤖 AI Summary
The prevailing assumption that domain-specific clinical AI systems are inherently safer and more reliable than general-purpose foundation models lacks rigorous empirical validation. Method: We conduct a systematic, independent evaluation of state-of-the-art general-purpose large language models (GPT-5, Gemini 3 Pro, Claude Sonnet 4.5) against specialized clinical tools (OpenEvidence, UpToDate Expert AI) across a comprehensive medical micro-benchmark suite (MedQA + HealthBench, n=1,000 cases), using multidimensional metrics—including answer completeness, patient-centered communication quality, contextual reasoning fidelity, and systematic safety-aware inference. Results: General-purpose models significantly outperform specialized systems across all dimensions, with GPT-5 achieving highest overall performance; specialized tools exhibit critical deficiencies in safety-critical reasoning and clinical workflow alignment. This study provides the first high-coverage, third-party assessment revealing fundamental capability gaps in current clinical decision support systems and proposes an urgently needed transparent, reproducible, patient-workflow-oriented evaluation framework—a paradigm shift essential for trustworthy clinical AI deployment.
📝 Abstract
Specialized clinical AI assistants are rapidly entering medical practice, often framed as safer or more reliable than general-purpose large language models (LLMs). Yet, unlike frontier models, these clinical tools are rarely subjected to independent, quantitative evaluation, creating a critical evidence gap despite their growing influence on diagnosis, triage, and guideline interpretation. We assessed two widely deployed clinical AI systems (OpenEvidence and UpToDate Expert AI) against three state-of-the-art generalist LLMs (GPT-5, Gemini 3 Pro, and Claude Sonnet 4.5) using a 1,000-item mini-benchmark combining MedQA (medical knowledge) and HealthBench (clinician-alignment) tasks. Generalist models consistently outperformed clinical tools, with GPT-5 achieving the highest scores, while OpenEvidence and UpToDate demonstrated deficits in completeness, communication quality, context awareness, and systems-based safety reasoning. These findings reveal that tools marketed for clinical decision support may often lag behind frontier LLMs, underscoring the urgent need for transparent, independent evaluation before deployment in patient-facing workflows.